Moderna, Inc. — Director's Dealing 2019

Sep 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2019-09-17

Reporting Person: HUTT PETER BARTON (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-17	Common Stock	M	100000	$.04	Acquired	103924	Direct
2019-09-17	Common Stock	S	100000	$17.63	Disposed	3924	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-17	Stock Option (Right to Buy)	$.04	M	100000	Disposed	2022-03-27	Common Stock (100000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.31 to $17.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F2: This option is fully vested and exercisable.